- Home
- LOCO vs KRRO Comparison
LOCO vs KRRO Comparison
Compare LOCO & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- KRRO
- Stock Information
- Founded
- LOCO 1980
- KRRO 2014
- Country
- LOCO United States
- KRRO United States
- Employees
- LOCO N/A
- KRRO N/A
- Industry
- LOCO Restaurants
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- LOCO Consumer Discretionary
- KRRO Health Care
- Exchange
- LOCO Nasdaq
- KRRO Nasdaq
- Market Cap
- LOCO 323.7M
- KRRO 358.3M
- IPO Year
- LOCO 2014
- KRRO 2019
- Fundamental
- Price
- LOCO $9.38
- KRRO $38.88
- Analyst Decision
- LOCO Buy
- KRRO Strong Buy
- Analyst Count
- LOCO 2
- KRRO 7
- Target Price
- LOCO $18.00
- KRRO $96.71
- AVG Volume (30 Days)
- LOCO 234.6K
- KRRO 241.5K
- Earning Date
- LOCO 10-30-2025
- KRRO 11-12-2025
- Dividend Yield
- LOCO N/A
- KRRO N/A
- EPS Growth
- LOCO N/A
- KRRO N/A
- EPS
- LOCO 0.85
- KRRO N/A
- Revenue
- LOCO $479,690,000.00
- KRRO $6,281,000.00
- Revenue This Year
- LOCO $6.13
- KRRO $116.91
- Revenue Next Year
- LOCO $1.56
- KRRO N/A
- P/E Ratio
- LOCO $11.21
- KRRO N/A
- Revenue Growth
- LOCO 1.85
- KRRO N/A
- 52 Week Low
- LOCO $8.29
- KRRO $10.29
- 52 Week High
- LOCO $13.24
- KRRO $76.79
- Technical
- Relative Strength Index (RSI)
- LOCO 43.13
- KRRO 47.86
- Support Level
- LOCO $9.37
- KRRO $38.02
- Resistance Level
- LOCO $9.88
- KRRO $40.97
- Average True Range (ATR)
- LOCO 0.27
- KRRO 4.85
- MACD
- LOCO 0.03
- KRRO -1.42
- Stochastic Oscillator
- LOCO 34.42
- KRRO 12.27
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.